FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma - Remke, Marc; Hielscher, Thomas; Korshunov, Andrey; Northcott, Paul A.; Bender, Sebastian; Kool, Marcel; Westermann, Frank; Benner, Axel; Şeker-Cin, Huriye; Ryzhova, Marina; Sturm, Dominik; Witt, Hendrik; et al. (Journal of clinical oncology, 2011)
Gesehen am 15.09.2022